We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
EPICENTRE Biotechnologies Announces the Release of Ribonuclease R
Product News

EPICENTRE Biotechnologies Announces the Release of Ribonuclease R

EPICENTRE Biotechnologies Announces the Release of Ribonuclease R
Product News

EPICENTRE Biotechnologies Announces the Release of Ribonuclease R


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "EPICENTRE Biotechnologies Announces the Release of Ribonuclease R"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

EPICENTRE Biotechnologies has announced the release of Ribonuclease R, a magnesium-dependent 3®5' exoribonuclease that digests essentially all linear RNAs but will not digest lariat or circular RNA structures.

Intron RNA can be isolated from total RNA samples by digestion with RNase R. After digestion, only lariat structures that are produced during the pre-mRNA splicing of intron regions remain. Applications include alternative splicing studies, gene expression studies, intron cDNA production, and intronic screening of cDNA libraries.

Advertisement